Search Results - "SUTFIN, T"

Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein: An Initial Multidose Study of Torcetrapib by Clark, Ronald W, Sutfin, Tamara A, Ruggeri, Roger B, Willauer, Ann T, Sugarman, Eliot D, Magnus-Aryitey, George, Cosgrove, Patricia G, Sand, Thomas M, Wester, Ronald T, Williams, John A, Perlman, Michael E, Bamberger, Mark J

“…OBJECTIVE—The ability of the potent cholesteryl ester transfer protein (CETP) inhibitor torcetrapib (CP-529,414) to raise high-density lipoprotein cholesterol…”
Get full text

Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM by BERELOWITZ, M, FISCHETTE, C, CEFALU, W, SCHADE, D. S, SUTFIN, T, KOURIDES, I. A

“…Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM. M Berelowitz , C…”
Get full text

Stereoselective interaction of omeprazole with warfarin in healthy men by Sutfin, T, Balmer, K, Boström, H, Eriksson, S, Höglund, P, Paulsen, O

“…The effect of concomitant treatment with omeprazole (20 mg/day) on the plasma concentration and anticoagulation effect of warfarin was studied in 21 young…”
Get more information

Contribution of the intestine to the first-pass metabolism of felodipine in the rat by Wang, S X, Sutfin, T A, Bäärnhielm, C, Regårdh, C G

“…The systemic availability of intraduodenally (i.d.) administered felodipine in the rat is about 10%. The purpose of this study was to determine to what extent…”
Get more information

Biliary secretion of felodipine metabolites in man after intravenous [14C]felodipine by SUTFIN, T. A, LIND, T, GABRIELSSON, M, REGARDH, C. G

“…The biliary secretion of [14C]felodipine in 4 healthy human subjects was studied by use of the multiple marker dilution principle with double lumen tubes…”
Get full text

The effect of felodipine on bile flow in pentobarbital anaesthetized rats and conscious rats receiving bile salt supplementation by WANG, S.-X, SUTFIN, T. A, REGARDH, C. G

“…Felodipine, a vasoselective dihydropyridine calcium antagonist, has been given i.v. (0.2 mumol/kg) to anaesthetized and conscious male rats. There was no…”
Get full text

Liquid-chromatographic determination of eight tri- and tetracyclic antidepressants and their major active metabolites by Sutfin, T A, D'Ambrosio, R, Jusko, W J

“…A "high-performance" liquid-chromatographic method is presented for monitoring the therapeutic concentrations, in plasma, of eight tri- and tetracyclic…”
Get more information

Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients by Sutfin, T A, Perini, G I, Molnar, G, Jusko, W J

“…Imipramine (IMI) and its active metabolites, desipramine (DMI), 2-hydroxyimipramine (2-OH-IMI), and 2-hydroxydesipramine (2-OH-DMI), were assayed by high…”
Get more information

Effects of biliary excretion on the disposition of felodipine and metabolites in the rat by Sutfin, T A, Gabrielsson, M, Regårdh, C G

“…1. After i.v. and intraduodenal administration of 3H-felodipine to rats, approx. 50% of the dose was excreted in bile in the first 6 h. Total urinary and…”
Get more information

The analysis and disposition of imipramine and its active metabolites in man by SUTFIN, T. A, DE VANE, C. L, JUSKO, W. J

“…Single oral and intramuscular (i.m.) doses of imipramine (IMI) were administered to four normal males. Serum and urine concentrations of IMI, desipramine (DMI)…”
Get full text

Early detection of aminoglycoside nephrotoxicity with urinary beta-2-microglobulin by Schentag, J J, Sutfin, T A, Plaut, M E, Jusko, W J

“…We used a radioimmunoassay to evaluate the changes in the urinary excretion of beta2-microglobulin (beta2M) in 21 patients receiving aminoglycosides for…”
Get more information

High-performance liquid chromatographic assay for imipramine, desipramine, and their 2-hydroxylated metabolites by Sutfin, T A, Jusko, W J

“…High-performance liquid chromatographic method is presented for the simultaneous determination of imipramine, desipramine, and their 2-hydroxylated metabolites…”
Get more information

Pharmacokinetics and Pharmacodynamics of Extended-Release Glipizide GITS Compared with Immediate-Release Glipizide in Patients with Type II Diabetes Mellitus by Chung, Menger, Kourides, Ione, Canovatchel, William, Sutfin, Tamara, Messig, Michael, Chaiken, Rochelle L.

“…This study was designed to compare the pharmacokinetic and short‐term pharmacodynamic profile of extended‐release glipizide GITS (Glucotrol XL®) given in a…”
Get full text

Active metabolites of imipramine and desipramine in man by Potter, W Z, Calil, H M, Sutfin, T A, Zavadil, 3rd, A P, Jusko, W J, Rapoport, J, Goodwin, F K

“…Active hydroxy metabolites of imipramine (IMI) and desipramine (DMI) have been quantified in plasma and cerebrospinal fluid (CSF) from patients at…”
Get more information

Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases by Devane, C L, Wolin, R E, Rovere, R A, Panahon, N C, Sutfin, T A, Jusko, W J

“…Six patients are described who achieved very high plasma concentrations of imipramine and desipramine during chronic therapy with usual doses. Side effects…”
Get full text